Skip to main content
Log in

High Expression of Patched Homolog-1 Messenger RNA and Glioma-Associated Oncogene-1 Messenger RNA of Sonic Hedgehog Signaling Pathway Indicates a Risk of Postresection Recurrence of Hepatocellular Carcinoma

  • Hepatobiliary Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Hepatocellular carcinoma (HCC) has a high recurrence rate after resection. Abnormal activation of the sonic hedgehog (SHH) signaling pathway contributing to the carcinogenesis of some organs had been reported. We hypothesize that activation of SHH pathway contributes to the recurrence of HCC after surgical resection.

Methods

In a prospective study, from January 2006 to June 2010, a total of 50 consecutive patients with HCC after curative resection were enrolled. The ratio of the expression of messenger RNA (mRNA) of SHH, patched homolog-1 (PTCH-1) and glioma-associated oncogene-1 (GLI-1) between HCC tissues and the paired noncancerous liver tissues were measured. Both the clinicopathologic characteristics and these ratios were compared between those with recurrence and those without recurrence. They were also compared between those with and without survival.

Results

There was a statistically significant correlation among the ratios of PTCH-1 mRNA and serum AFP level (p = 0.045), tumor size (p = 0.001), vascular permeation (p = 0.043) and tumor, node, metastasis staging system (TNM) stage (p = 0.003). A borderline significant correlation was found among ratios of GLI-1 mRNA and tumor size (p = 0.062) and TNM stage (p = 0.051). There was no such significant correlation between SHH mRNA and any parameter. Both the ratios of PTCH-1 mRNA and GLI-1 mRNA significantly adversely affected recurrence (p = 0.003 and 0.005, respectively) and survival (p < 0.001 and <0.001, respectively).

Conclusions

Expression of PTCH-1 mRNA and GLI-1 mRNA in HCC tissues is a potential biomarker to predict postresection disease recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010;15:5–13.

    Article  PubMed  Google Scholar 

  2. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–6.

    Article  PubMed  CAS  Google Scholar 

  3. Island ER, Pomposelli J, Pomfret EA, Gordon FD, Lewis WD, Jenkins RL. Twenty-year experience with liver transplantation for hepatocellular carcinoma. Arch Surg. 2005;140:353–8.

    Article  PubMed  Google Scholar 

  4. Poon RT, Fan ST, Wong J. Risk factors, prevention, and management of post-operative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10–24.

    Article  Google Scholar 

  5. Jeng KS, Chen BF, Lin HJ. En bloc resection for extensive hepatocellular carcinoma: is it advisable? World J Surg.1994;18:834–9.

    Article  PubMed  CAS  Google Scholar 

  6. Chen MF, Hwang TL, Jeng LB, Wang CS, Jan YY, Chen SC. Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg. 1994;129:738–42.

    Article  PubMed  CAS  Google Scholar 

  7. Kondo K, Chijiiwa K, Makino I, et al. Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2005;12:399–404.

    Article  PubMed  Google Scholar 

  8. Agathocleous M, Locker M, Harris WA, Perron M. A general role of hedgehog in the regulation of proliferation. Cell Cycle. 2007;6:156–9.

    Article  PubMed  CAS  Google Scholar 

  9. Ingham PW. Transducing hedgehog: the story so far. EMBO J.1998;17:3505–11.

    Article  PubMed  CAS  Google Scholar 

  10. Harmon EB, Ko AH, Kim SK. Hedgehog signaling in gastrointestinal development and disease. Curr Mol Med. 2002;2:67–82.

    Article  PubMed  CAS  Google Scholar 

  11. Chari NS, McDonnell TJ. The sonic hedgehog signaling network in development and neoplasia. Adv Anat Pathol. 2007;14:344–52.

    Article  PubMed  CAS  Google Scholar 

  12. Taipale J, Beachy PA. The hedgehog and wnt signaling pathways in cancer. Nature. 2001;411:349–54.

    Article  PubMed  CAS  Google Scholar 

  13. Warkins DN, Peacock CD. Hedgehog signaling in foregut malignancy. Biochem Pharmacol. 2004;68:1055–60.

    Article  Google Scholar 

  14. Thayer SP, diMagliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature. 2003;425:851–6.

    Article  PubMed  CAS  Google Scholar 

  15. Ma X, Chen K, Huang S, et al. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis. 2005;26:1698–705.

    Article  PubMed  CAS  Google Scholar 

  16. Karhadkar SS, Bova GS, Abdallah N, et al. Hedgehog signaling in prostate regeneration, neoplasia and metastasis. Nature. 2004;431:707–12.

    Article  PubMed  CAS  Google Scholar 

  17. Ma X, Sheng T, Zhang Y, et al. Hedgehog signaling is activated in subsets of esophageal cancers. Int J Cancer. 2006;118:139–48.

    Article  PubMed  CAS  Google Scholar 

  18. Bale AE, Yu KP. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet. 2001;10:757–62.

    Article  PubMed  CAS  Google Scholar 

  19. Che L, Ren J, Yuan YH, et al. Expression of genes related to sonic hedgehog signaling in human hepatocellular carcinomas. Beijing Da Xue Xue Bao. 2008;40:616–23.

    PubMed  CAS  Google Scholar 

  20. Sicklick JK, Li YX, Jayaraman A, et al. Dysregulation of the hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis. 2006;27:748–57.

    Article  PubMed  CAS  Google Scholar 

  21. Huang S, He J, Zhang X, et al. Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis. 2006;27:1334–40.

    Article  PubMed  CAS  Google Scholar 

  22. Cheng WT, Xu K, Tian DY, Zhang ZG, Liu LJ, Chen Y. Role of hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells. Int J Oncol. 2009;34:829–36.

    PubMed  CAS  Google Scholar 

  23. Fu X, Wang Q, Chen X, et al. Expression patterns and polymorphisms of PTCH in Chinese hepatocellular carcinoma patients. Exp Mol Pathol. 2008;84:195–9.

    Article  PubMed  CAS  Google Scholar 

  24. Choi SS, Omenetti A, Witek RP, et al. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2009;297:G1093–106.

    Article  PubMed  CAS  Google Scholar 

  25. Athar M, Li C, Tang X, Chi S, et al. Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res. 2004;64:7545–52.

    Article  PubMed  CAS  Google Scholar 

  26. Adolphe C, Hetherington R, Ellis T, Wainwright B. Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res. 2006;66:2081–8.

    Article  PubMed  CAS  Google Scholar 

  27. Barnes EA, Kong M, Ollendorff V, Donoghue DJ. Patched1 interacts with cyclin B1 to regulate cell cycle progression. EMBO J. 2001;20:2214–23.

    Article  PubMed  CAS  Google Scholar 

  28. You S, Zhou J, Chen S, et al. PTCH1, a receptor of hedgehog signaling pathway, is correlated with metastatic potential of colorectal cancer. Ups J Med Sci. 2010;115:169–75.

    Article  PubMed  Google Scholar 

  29. Wang Q, Huang S, Yang L, et al. Down-regulation of sonic hedgehog signaling pathway activity is involved in 5-fluorouracil-induced apoptosis and motility inhibition in Hep3B cells. Acta Biochim Biophys Sin (Shanghai). 2008;40:819–29.

    CAS  Google Scholar 

  30. Mori Y, Okumura T, Tsunoda S, et al. GLI-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma. Oncology. 2006;70:378–89.

    Article  PubMed  CAS  Google Scholar 

  31. ten Haaf A, Bektas N, von Serenyi S, et al. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavorable overall survival. BMC Cancer. 2009;25;9:298.

    Article  Google Scholar 

  32. Jeng KS, Sheen IS, Tsai YC. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection? Am J Gastroenterol. 2004;99:1503–9.

    Article  PubMed  Google Scholar 

  33. Berman DM, Karhadkar SS, Hallahan AR, et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science. 2002;297:1559–61.

    Article  PubMed  CAS  Google Scholar 

  34. Chen XL, Cheng QY, She MR, et al. Expression of sonic hedgehog signaling components in hepatocellular carcinoma and cyclopamine-induced apoptosis through Bcl-2 downregulation in vitro. Arch Med Res. 2010;41:315–23.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

Supported in part by Far Eastern Memorial Hospital and by financial support from a research grant of National Science Council. Executive Yuan, Taiwan, ROC (NSC-97-2314-B-418-008-MY3, Taiwan).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to I-Shyan Sheen MD or Wen-Juei Jeng MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeng, KS., Sheen, IS., Jeng, WJ. et al. High Expression of Patched Homolog-1 Messenger RNA and Glioma-Associated Oncogene-1 Messenger RNA of Sonic Hedgehog Signaling Pathway Indicates a Risk of Postresection Recurrence of Hepatocellular Carcinoma. Ann Surg Oncol 20, 464–473 (2013). https://doi.org/10.1245/s10434-012-2593-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-012-2593-y

Keywords

Navigation